The IND application of the Group's first project, GT0918 (Proxalutamide tablets), has been submitted for prostate cancer indications
- Categories:The development course
- Author:
- Origin:
- Time of issue:2013-01-01 10:41
- Views:
(Summary description)
The IND application of the Group's first project, GT0918 (Proxalutamide tablets), has been submitted for prostate cancer indications
(Summary description)
- Categories:The development course
- Author:
- Origin:
- Time of issue:2013-01-01 10:41
- Views:
Information
The IND application of the Group's first project, GT0918 (Proxalutamide tablets), has been submitted for prostate cancer indications
Scan the QR code to read on your phone